Bolsonaro Faces Probe for Alleged Negligence in Vaccine Case
(Bloomberg) -- Brazil's prosecutor general office has requested the country's top court to investigate President Jair Bolsonaro for possible negligence in the handling of corruption allegations related to the purchase of vaccines from India.
Negotiations to buy the Covaxin shot produced by Bharat Biotech International Ltd. turned into a scandal when a government ally said he had personally warned Bolsonaro that a contract signed by the Health Ministry to acquire 20 million doses of the vaccine for 1.6 billion reais ($317 million) was plagued with irregularities.
“It must be clarified what measures have been taken after the meeting” between the president and his ally, said Deputy Prosecutor General Humberto Jacques de Medeiros in a decision published on Friday.
The ally, lower house representative Luis Miranda, described a series of problems in the negotiations, including the use of an intermediary company, during his testimony to a congressional committee that's already scrutinizing the government's handling of the pandemic. Although there's no indication that Bolsonaro would personally benefit from the transaction, members of that committee asked the top court to investigate him for turning a blind eye to the allegations.
Justice Rosa Weber, who's responsible for the case at the top court, requested the opinion of the prosecutor general before making a decision. The deputy prosecutor general then asked for the court's authorization to hear from all those involved and for the congressional committee to share with police any evidence collected so far.
Political Headache
The Brazilian real briefly erased early gains on news of the probe, which was first reported by Globonews TV. It traded little changed at 5.05 per dollar at 4:55 p.m. in Sao Paulo.
A police investigation authorized by the supreme court is the latest political headache for Bolsonaro, who already faces an additional 90 days of a congressional probe into his handling of the pandemic. The findings of the Senate committee have encouraged the opposition to file a “super impeachment” request against the president, combining all the elements from more than 100 previous petitions that are piling up on the desk of lower house Speaker Arthur Lira, a government ally.
Read More: Brazil to Extend Covid Probe in Headache for Bolsonaro
The police investigation is also supposed to last 90 days, after which the prosecutor general must decide whether to shelve the case or press charges against the president. If accused of a crime, the lower house needs to authorize the top court to put him on trial.
“Even if the results of the investigation aren't shelved by the prosecutor general, which seems to be he most likely outcome, lawmakers won't allow Bolsonaro to stand trial at the top court,” said Bruno Salles, head of the Brazilian Criminal Sciences Institute and a partner at a law firm in Sao Paulo. “There have been two such attempts against former President Michel Temer recently, and both were rejected. I don't see it happening now.”
Bolsonaro's office declined to comment. Since the scandal broke, Bolsonaro has said he can't follow everything that's happening in the government and that he trusts his ministers. He has also said he was unfairly accused of corruption for a vaccine purchase that was never concluded.
After signing the contract to purchase the Covaxin doses, the Health Ministry suspended it earlier this week “for a deeper analysis.” No payment has been made and no vaccines have been delivered. Bolsonaro on Wednesday fired a Health Ministry official who was cited as putting unusual pressure to accelerate the deal.
©2021 Bloomberg L.P.
-
India's Troika Of Good Luck | Joining The Dots
A weaker Trump, a cooling AI trade and resilient earnings have put Indian markets back in favour. Rising inflation could spoil the party.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.